Modified Glasgow-Blatchford Bleeding Score as an Alternative Predictors of Severity for Non-Variceal Upper Gastrointestinal Bleeding by Abdullah, T. (Taufiq) et al.
 91
Alternative Predictors of Severity for Gastrointestinal Bleeding (Abdullah T, et al.)Indones  Biomed J. 2016; 8(2): 91-6DOI: 10.18585/inabj.v8i2.214
R E S E A R C H  A R T I C L E
Modified Glasgow-Blatchford Bleeding Score as an Alternative Predictors of 
Severity for Non-Variceal Upper Gastrointestinal Bleeding
Taufiq Abdullah1,, Siswanto2, Bogi Pratomo3
1Emergency Department, Dr. Saiful Anwar Hospital, Faculty of Medicine, Brawijaya University, Jl. Veteran, Malang, Indonesia
2Public Health Department, Dr. Saiful Anwar Hospital, Faculty of Medicine, Brawijaya University, Jl. Veteran, Malang, Indonesia
 3Division of Gastroenterohepatology, Internal Medicine Department, Dr. Saiful Anwar Hospital, Faculty of Medicine, Brawijaya University, Jl. Veteran, 
Malang, Indonesia
Corresponding author. E-mail: taufiqabdullahdr@gmail.com
Received date: Nov 20, 2015; Revised date: Jan 22, 2016; Accepted date: Apr 6, 2016
BACKGROUND: Upper gastrointestinal bleeding (UGIB) is a frequent cause of emergency hospital admissions. Despite the dependency of most risk 
scoring systems for this disorder, the Glasgow-Blatchford 
bleeding score (GBS) is based on simple variables. This 
research intended for investigate the accuracy of a modified 
GBS (mGBS) to predict the severity of non-variceal UGIB.
METHODS: Study conducted in Emergency Department 
of Dr. Saiful Anwar Hospital, Malang, from November 
2012 to April 2013. Endoscopy performed between 12-24 
hours after the patient stabilized. Sixty patients diagnosed 
were included. The accuracy of the mGBS in predicting the 
severity of non-variceal UGIB was compared with the full 
GBS using receiver operating characteristic (ROC) curve. 
The severity based on high risk in mGBS score compared 
by Forrest classification.   
RESULTS: For prediction of the severity of non-variceal 
UGIB, the GBS (AUC 0.947, 95% CI 0.87-1.03) had a 
slightly had a slightly higher accuracy than the mGBS (AUC 
0.943, 95% CI 0.86-1.02, p<0.01). Compared to the GBS, 
the mGBS was more specific (63% and 97%, respectively) 
but less sensitive (96% and 84%, respectively). 
CONCLUSION: The mGBS is an alternative diagnostic 
tool in predicting the severity of non-variceal UGIB. 
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Abstract
Introduction
Upper  gastrointestinal bleeding (UGIB) is the emergency 
case commonly found either in the hospital or in the center 
of primary health care. The case fatality rate is estimated 
at 10% and has not changed significantly since 1960s. 
Therefore, diagnostic modalities should take precedence 
over the therapeutic techniques. UGIB is often easily 
identified in the patient presenting with vomiting blood 
(hematemesis) or passing black, tarry stools (melena). 
Such complaints are usually  accompanied  by signs and 
symptoms of hypovolemia such as dizziness, weakness, or 
syncope.(1)
 In the United States, approximately 350,000 patients 
are hospitalized due to UGIB each year, and 35-45% of 
them are over 60 years old. The incidence of UGIB ranges 
between 50 and 150 per 100,000 of the population per year. 
About 60% of women aged 60 years or older are estimated 
to have experienced this case. Meanwhile, according to 
study conducted in the United Kingdom, UGIB mortality 
rate is approximately 14% of the total population, and only 
0.6% for those younger than 60 years without the presence 
of malignancy or organ failure. Almost all reported cases 
of death in the older people are due to a serious illness that 
accompanies.(1,2,3) 
 In Indonesia, according to the medical records of 
patients admitted to the Internal Medicine Department of 
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Hasan Sadikin Hospital, Bandung, in 1996-1998, there 
were 2.5-3.5 % patients treated for UGIB of all patients. 
In Saiful Anwar hospital, Malang, in January-June 2013, 
there were 124 cases patients UGIB undergoing endoscopic, 
60% patients with non-variceal. Data in 2008, there are only 
733 patients (2%) come to emergency departement Saiful 
Anwar hospital with complain hematemesis, melena, or 
both. From endoscopic results, we found gastritis erosive 
(40%), gastritis erythematous (11%), ulcus duodenum (5%), 
ulcus gaster (18%), varices esofagus (13%), and the others 
(13%). The overall mortality of UGIB is high at around 
25%, and mortality in patients with rupture of varices can 
reach 60%. The most common cause of death in patients 
with UGIB is not because of the bleeding itself, but because 
of other diseases.(4-7)
 It is still difficult to predict a severity for the patients 
presenting with variceal bleeding. Some literatures stated 
that the clinical signs of cirrhosis, portal hypertension, and 
spontaneous hematemesis accompanied by hemodynamic 
changes may indicate the possibility of variceal bleeding. 
However, this statement is still difficult to be confirmed or 
validated. Studies suggested that in patients with cirrhosis 
and first time variceal bleeding, about  40% did  not 
reveal any  signs  of  chronic  liver  disease  and  portal 
hypertension.(5,8)
 The non-variceal UGIB is commonly caused by peptic 
ulcer, erosive gastroduodenitis, reflux esophagitis, tumor, 
and others.(5,6) Sometimes coffee-ground color is also 
found in the nasogastric (NG) tube of patients with a history 
of  non-steroidal anti-inflammatory drug (NSAID) intake. 
However, this fact is still difficult to be proven. Peptic ulcer 
disease is the hardest and most frequent case of non-variceal 
UGIB, which is about 60% of cases, but approximately 
80% of the ulcer bleeding may stop spontaneously without 
any intervention. Helicobacter pylori (H. pylori) is also 
commonly attributed as the cause of chronic gastritis, 
peptic ulcers, and gastric cancer. In certain condition, such 
as gastric mucosal damage caused by NSAIDs, H. pylori 
is able to invade the gastric mucosa causing inflammation 
resulting in acute non-erosive gastritis, then this can quickly 
progress to peptic ulcer (15-25%).(9,10) However, the 
prevalence of gastritis due to H. pylori in Indonesia is not 
yet known exactly.
 There are many clinical scoring systems have been 
developed to direct appropriate patient management. 
These systems using a combination of many variables to 
produce a score that predicts the risk of haemorrhage, for 
clinical intervention or suitability for discharge. Although 
these systems are very accurate, they are limited by the 
availability of endoscopy within 24 hours, especially in our 
country. Factors commonly associated with poor outcome 
from UGIB may be related to the patient’s presentation 
and morbidities, or the ulcer. Risk stratification using 
nonendoscopic parameters has the advantage that it can be 
performed readily on initial presentation in the emergency 
department, and appropriate initial risk assessment is still 
possible, even if early endoscopy, which requires skilled 
staff and resources, is not always available.(2,4,8,11)
 As before, the Glasgow-Blatchford bleeding score 
(GBS) was derived from logistic regression analysis of 
clinical and laboratory values used to predict need for 
hospital intervention or death. For prediction of need 
for intervention or death, the GBS was superior to both 
admission and full Rockall scores.(4,12) In which this 
study, we investigate the accuracy the GBS compared with 
new modified score. We add the new parameter in that 
GBS, includes history of hematemesis, renal disease, and 
NSAIDs or herbal medicine intake, as well as laboratory 
tests of hemostasis and H. pylori IgG antibody, to predict 
the severity of non-variceal UGIB.
Study Design and Population
The study design is a diagnostic test. Based on ethical 
clearance No. 368/KEPK/XI/2012, this study conducted in 
Emergency Department and Endoscopy Unit of Dr. Saiful 
Anwar Hospital, Malang, from November 2012 to April 
2013. All patients presenting with non-variceal UGIB were 
evaluated. Endoscopy performed between 12-24 hours after 
the patient stabilized. Patients who refused endoscopic 
examination or without consents were excluded. This study 
had been approved by the institutional ethics committee of 
Dr. Saiful Anwar Hospital, Malang, and informed consents 
were obtained from all enrolled patients. 
Survey Content and Administration
The diagnosis of non-variceal UGIB was based on patients’ 
presentation, including hematemesis, coffee-ground emesis, 
and melena. Variables including age, sex, chief complaints, 
presenting vital signs, presence of comorbid medical 
conditions (heart disease, liver disease, and kidney disease), 
history of medication with NSAIDs or herbs, laboratory data 
(hemoglobin/Hb, blood urea nitrogen/BUN, hemostasis, 
and H. pylori IgG antibody), and the findings of endoscopy 
were recorded. The high-risk patient was defined as patient 
needing blood transfusion, therapeutic endoscopy to control 
bleeding, or surgical intervention to control bleeding. 
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Results
Table 1. The comparison of characteristics in high- and low-
risk patients stratified by occupation.
Data Analysis
Diagnostic tests were used to assess the relationship between 
the modified GBS (mGBS) and endoscopic (Forrest) score. 
High risk if we found there were active bleeding or adherent 
clots (Ia-IIb). High risk in mGBS if we calculate the score 
more than 11. The severity based on high risk score from 
both of them. The Chi-square tests and independent t-tests 
were first performed to assess the statistically significant 
differences between each of the parameters be used in the 
mGBS. Only probability values of p<0.05 were considered 
statistically significant. Diagnostic tests were performed 
to assess the sensitivity, specificity, positive predictive 
value, negative predictive value, and  receiver operating 
characteristic (ROC) curves with 95% confidence interval 
(CI). Statistical analysis were performed using the software 
SPSS17.0 for Windows.
A total of 60 patients were enrolled in this study consisted 
of 34 men (56%) and 26 women (44%). Subjects aged 
under 60 years (63%), between 60-69 years (27%), and 
over 69 years (10%). Based on the chief complaints, 29 
subjects (48%) present with melena, 21 subjects (35%) with 
hematemesis, and 16 subjects (27%) with hematemesis and 
melena. Based on the hemodynamic conditions, 54 subjects 
(90%) had a systolic blood pressure (SBP) of more than 
99 mmHg, 36 subjects (60%) had a normal pulse between 
80-100/min, and only 1 subject (1.7%) had a history of 
syncope. Based on morbidity, only 10 subjects had history 
of heart disease (17%), 8 subjects (13.3%) had liver disease, 
and 7 subjects (11.7%) had kidney disease. Based on the 
history, there were 41 subjects (68.3%) had a history of 
taking NSAIDs/herbal medicine and only 1 subject (1.7%) 
had a history of H. pylori infection. Meanwhile, according 
to laboratory data, 31 subjects (51.7%) had Hb <10 g/dL, 
29 subjects (48.3%) had Hb >10g/dL, 28 subjects (47%) 
had abnormal blood urea nitrogen (BUN) values, while 32 
subjects (53%) had normal BUN values, and only 1 subject 
(1.7%) had abnormal hemostatic value. The characteristic 
data are shown in Table 1.
 The patients were categorized as high-risk and low-
risk. The independent t-tests (Table 1) showed that the SBP 
and pulse were not significantly different, but hemoglobin 
and BUN were significantly (p<0.05) different between 
the 2 groups. The Chi-Square tests (Table 1) indicated not 
significant differences in syncope, history of heart or liver 
disease, intake of NSAID’s or herbal medicine, hemostasis 
High Risk Low Risk
n (%)        n (%)
SBP: mean±SD 122.00±32.44 114.6±17.81 0.332
Pulse: mean±SD 103.64±18.28 96.24±19.05 0.147
HEMATEMESIS
Negative 10  (45.45) 29  (76.32)
Positive 12  (54.55) 9  (23.68)
MELENA
Negative 5  (22.73) 26  (68.42)
Positive 17  (77.27) 12  (31.58)
SYNCOPE
Negative 21  (95.45) 38  (100)
Positive 1  (4.55) 0  (0)
HEART DISEASE
Negative 18  (81.82) 32  (84.21)
Positive 4  (18.18) 6  (15.79)
LIVER DISEASE
Negative 17  (77.27) 35  (92.11)
Positive 5  (22.73) 3  (7.89)
KIDNEY DISEASE
Negative 16  (72.73) 37  (97.37)
Positive 6  (27.27) 1  (2.63)
*NSAIDs/HERBSUSE
Negative 4  (18.18) 15  (39.47)
Positive 18  (81.82) 23  (60.53)
Hb: mean ± SD 6.70±2.52 11.03±1.88 0.000
BUN: mean ± SD 48.62±43.54 19.0114.45 0.005
HEMOSTASIS TEST VALUE
Abnormal 21  (95.45) 38  (100)
Normal 1  (4.55) 0  (0)
H. pylori IgG ANTIBODY
Negative 22  (100) 37  (97.37)
Positive 0  (0) 1  (2.63)
ENDOSCOPY
High Risk 21  (84) 4  (16)
Low Risk 1   (2.9) 34   (7.1)
The mGBS
pCharacteristics
0.016
0.185
0.443
0.000
*NSAIDs indicates nonsteroidal anti-inflammatory drug
0.001
0.185
0.811
0.103
0.004
0.088
test value, and H. pylori IgG antibody between the 2 groups. 
Whereas, there were significant (p<0.05) differences in 
hematemesis, melena, and kidney disease between the 2 
groups.
 The tests of normality with Kolmogorov-Smirnov 
tests showed that the data of GBS and the mGBS had normal 
distributions (p>0.05). The t-tests indicated a significant 
(p<0.01) difference between GBS and the mGBS. Moreover, 
the mGBS (8.87±4.20) had higher average score than GBS 
(7.80±3.85) (Table 2).
 The ROC curve was performed to determine the 
accuracy of the mGBS in predicting the severity of non-
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Table 3. Diagnostic tests of GBS and the mGBS.
Discussion
variceal UGIB compare to GBS. The GBS (AUC 0.947, 
95% CI 0.87-1.03) had a slightly higher accuracy than the 
mGBS (AUC 0.943, 95% CI 0.86-1.02, p<0.01) (Figure 1). 
This suggested that GBS is superior than mGBS to assess 
severity of non-variceal UGIB.
 This study also indicated that the limit of scores in 
determining the severity of non-variceal UGIB was not 
much different between GBS and the mGBS, where a 
score of 10 is the minimum score considered high risk in 
patients with non-variceal UGIB (GBS of 10, sensitivity 
88%, specificity 100%; the mGBS of 10, sensitivity 92%, 
specificity 85%) (Figure 2).
 Diagnostic tests indicated that the GBS in diagnosing 
the severity of non-variceal UGIB had a higher sensitivity 
than the mGBS (96% and 84%, respectively), but a lower 
specificity than the mGBS (63% and 97%, respectively). 
The accuracy of GBS in predicting positive value was lower 
than the mGBS (PPV, 65% and 95%, respectively), but 
higher in predicting negative value (NPV, 96% and 89%, 
respectively) (Table 3).
Table 2. Independent t-tests of each parameter of GBS and the 
mGBS.
The results showed that only hemoglobin, BUN, 
hematemesis, melena, and kidney disease were significant 
in the mGBS. Whereas, SBP, pulse, syncope, heart disease, 
liver disease, hemostasis, H. pylori IgG antibody, and intake 
of NSAIDs/herbal medicine were not significant in the 
mGBS. Hematemesis and melena, according to the previous 
study, were proved as an early manifestation of UGIB, both 
variceal and non-variceal, where approximately 30% of 
patients with bleeding ulcers begins with hematemesis, 20% 
with melena, and 50% both.(5,13)
 Patients with a history of UGIB is usually followed by 
a significant decrease in hemoglobin. This study indicated 
a significant difference between the increase in the mGBS 
and the decline in hemoglobin in patients with UGIB. It is 
also supported by the data of patients presenting UGIB; 
approximately 51.7% of patients is characterized by 
decreased hemoglobin. Besides hemoglobin, hematocrit 
is also a useful test. Hematocrit value can determine the 
presence of anemia or polycythemia. Significant changes in 
hematocrit indicated blood loss. Infusion of normal saline 
can accelerate the equilibration of hematocrit, but a rapid 
infusion of crystalloid in non-bleeding patients can lower the 
hematocrit value due to hemodilution. Optimal hematocrit 
value in regulating the oxygen carrying capacity and 
viscosity in critically ill patients reaches 33%. In general, 
High risk Low risk High risk Low risk
Endoscopy: high risk 24 13 21 1
Endoscopy: low risk 1 22 4 34
Sensitivity
Specificity
Positive predictive value 
Negative predictive value 89%
GBS mGBS
96%
63%
65%
96%
84%
97%
95%
Variable Mean±SD t-statistic p
Total Blatchford score 7.80±3.85
Total modified Blatchford score 8.87±4.20
-9.824 0.000
acute bleeding patients with hemoglobin of 8g/dL or less 
(hematocrit less than 25%) need blood transfusion. After 
transfusion, and certainty no blood loss again, hematocrit 
is expected to increase by 3% in any given unit of blood 
(hemoglobin increased by 1g/dL).(1)
 BUN increased in patients with UGIB because of blood 
absorption in the gastrointestinal tract and hypovolemia that 
can lead to renal failure. This study showed that nearly half 
of non-variceal UGIB patients (47%) had abnormal BUN 
value. This suggested that patients with abnormal BUN 
value may cause UGIB symptoms. Ratio of BUN and serum 
creatinine can also be used to estimate the origin of bleeding. 
The peak ratio is between 24-48 hours from the onset of 
bleeding, and the ratio of 20 is considered normal. The ratio 
of more than 35 indicates that the bleeding source may be 
from UGIB. After 24 hours, hypovolemia predominantly 
leads to azotemia if there is recurrent bleeding.(1,7,14)
 The history of kidney disease significantly aggravates 
UGIB due to the uremia or too much ammonia accumulating 
in the patient's body, thus causing either of gastritis, peptic 
ulcer disease, and gastric mucosal ulceration at various 
levels. Some studies suggested that uremia may affect the 
aggregation of platelets (coagulation), so it can prolong 
bleeding in renal failure patients with UGIB.(15,16) 
The upper gastrointestinal tract lesions in patients with 
renal failure is still unclear. Some mechanism of studies 
indicated that hypergastrinemia plays a role in increasing 
the acid secretion resulting in the gastrointestinal lesions, 
but another study showed that  hypergastrinemia  actually 
causes  hypochloridia.  Other  studies  also  suggested 
that H. pylori played an important role in increasing the 
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Figure 1. Comparison of GBS and the mGBS with AUC figures. 
(GBS, AUC 0.947, 95% CI 0.87-1.03; the mGBS, AUC 0.943, 
95% CI 0.86-1.02).
Figure 2. Comparison of GBS and the mGBS in determining 
the severity of non-variceal UGIB. (GBS score of 10, sensitivity 
88%, specificity 100%; the modified GBS score of 10, sensitivity 
92%, specificity 85%).
prevalence of gastrointestinal lesion in patients with renal 
failure. Although it is still controversial whether the risk of 
H. pylori infection is greater in patients with renal failure 
compared  to  normal  people,  previous  study indicated 
that the  prevalence of H.pylori  infection  is  about 49-66% 
in patients  with  renal  failure,  and  about  35-75%   in  the 
normal.(15)
 There were no significant differences in SBP, pulse, 
and syncope to the risk of UGIB. This may occur because 
of bleeding in patients with non-variceal UGIB is not as 
much as in variceal UGIB. This study showed that patients 
categorized as high risk in GBS had SBP over 122 mmHg 
and pulse above 103 x/min, while syncope occurred in 
only one patient. This suggested that non-variceal UGIB 
patients arriving at the hospital generally did not have 
significant hemodynamic disturbances. Acute hemorrhage 
in the amount exceeding 20% of the intravascular volume 
will result in an unstable hemodynamic conditions, such as 
hypotension (blood preassure/BP less than 90/60 mmHg or 
mean arterial pressure/MAP less than 70 mmHg), pulse over 
100x/min, diastolic blood pressure fall more than 10 mmHg 
or systolic blood pressure fall more than 20 mmHg, cold 
acral, decreased consciousness, syncope, and even anuria or 
oliguria (urine output less than 30 mL/hour). In addition, 
acute bleeding can also be characterized by hematemesis, 
hematochezia, and fresh blood on the NG that was not 
immediately clear with lavage, persistent hypotension, 
and the need of blood transfusion exceeding 800-1000 mL 
within 24 hours.(5)
 Although this study suggested that a history of heart 
disease was not significant in patients with non-variceal 
UGIB, but patients with heart disease can aggravate the risk 
of UGIB with age due to unstable hemodynamic conditions. 
Decreased cardiac output can cause gastric mucosa ischemia, 
increased risk of ulceration, and potentially bleeding. The 
constant use of drugs such as aspirin in patients with a 
history of coronary heart disease may also play a role in 
increasing the risk of UGIB.(5,17)
 This study also showed that there was no significant 
history of liver disease in patients with non-variceal UGIB. 
The effects of liver disease or cirrhosis is more apparent in 
patients with variceal UGIB. Complications of cirrhosis can 
lead to the bleeding of esophageal varices, splenomegaly, 
ascites, portal hypertension, hepatic encephalopathy, 
spontaneous bacterial peritonitis, hepatorenal syndrome, 
and liver cancer.(7,13,15,18,19) In cirrhotic patients, 
disorders of coagulopathy and hemostasis manifested as 
profuse gastrointestinal tract bleeding. On the other hand, 
there were no significant changes in hemostasis in non-
variceal UGIB. Thus, it was probable that the bleeding 
occurred have not yet induced coagulation disorders and the 
liver function of patients was good.
 The role of H. pylori infection and NSAIDs/herbal 
medicine as etiology of non-variceal UGIB remains unclear. 
In white population, studies showed that UGIB was mostly 
caused by H. pylori infection.(3,7,9,10,14,18) H. pylori 
infection occurs in approximately 95% of patients with 
duodenal ulcers and about 70% of patients with gastric 
ulcers. However, in this study the result of H. pylori IgG 
antibody test and the history of NSAIDs/herbal medicine 
use were not significant. There was a possibility that the 
results of H. pylori tests were not significant because of the 
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false negative results due to the samples were obtained from 
blood, instead of gastric mucosal biopsy (histopathology) 
which is more accurate. The history of taking NSAIDs or 
herbal medicine, although not significant, still served as the 
etiology of non-variceal UGIB in Indonesia, particularly in 
Saiful Anwar Hospital, Malang.
 Diagnostic test results indicated that GBS has a slightly 
superior sensitivity but lower specificity compared to the 
modified GBS. This proved that the modified GBS can be 
used as an alternative to endoscopy which is still be a gold 
standard in diagnosing the severity of patients presenting 
non-variceal UGIB. These results were also supported by 
the high PPV and NPV in the mGBS compared to GBS. 
The data confirmed that the mGBS can be used as an initial 
screening to determine the severity of patients presenting 
with non-variceal UGIB.
The mGBS can be used as an alternative tools in determining 
the severity of patients presenting with non-variceal 
UGIB. Certainly, the use of the mGBS is only as far early 
detection (early screening), particularly in the community 
health service centers and hospitals in Indonesia, where is 
endoscopy equipment not available. More parameter that we 
add in mGBS make this predictor more specific to predict 
the severity patients with non variceal UGIB. Finally, due 
to the scientific development and the use of the mGBS as 
an early predictor of the severity of patients presenting with 
non-variceal UGIB, further research is needed with a larger 
sample and longer time of research.
Conclusion
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